Source: Annual Congress 2002 - Prevalence and costs of COPD
Disease area: Airway diseases

Abstract

Introduction: Despite its high prevalence in industrialised countries, few prospective studies have been conducted on the costs of Chronic Obstructive Pulmonary Disease (COPD).
Objective: to investigate the costs attributable to COPD in subjects in steady state.
Methods: the present study is a part of the SIRIBO, a multi-center, prospective cohort study with the objectives to estimate the incidence, etiology, and costs of exacerbations of COPD in Italy; Design: Cost of Care study; Patients and setting: ambulatory COPD patients 40 years or older with COPD in steady state; Information: demographic, clinical, and economic, collected with ad hoc questionnaires; Follow-up: in general, patients were visited at enrollment, after 6 months and at 1 year; costs were assessed also at months 2, 4, 8 and 10 via phone interview; Perspective: National Health Service; Costs: healthcare and assistance costs (visits, drugs, assistance, hospitalisation, oxygen therapy) have been calculated in € 2001 and are expressed as cost per patient/month.
Results: 579 subjects, 81% male, 67(8) y.o. were validly enrolled in the economic module of SIRIBO. Results are presented in table, stratified by sex.
Discussion: in light of its high prevalence, the economic impact of COPD is notable, in terms of the management of both the disease itself and its exacerbations.

Variable	Cost of COPD management (¿ per person/month)	Costs of exacerbations (¿ per person/month)
Subjects (n)	579	579
Sex
Females	117	141
Males	79	118

Rating:

Share or cite this content

Citations should be made in the following way:
L. G. Mantovani, S. Mannino, C. F. Donner, R. M. Busca, M. C. J. M. Sturkenboom (Milan, Segrate, Verona, Italy; Rotterdam, The Netherlands). The cost of COPD: results from the SIRIBO study. Eur Respir J 2002; 20: Suppl. 38, 832

Member's Comments

No comment yet.

Related content which might interest you: Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 The cost analysis of our COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018 DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK) Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020 Worldwide under-diagnosis of COPD: results from the bold study Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 NIV after acute exacerbation of COPD: results from the Dutch multicentre study Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD Year: 2015 Real-life COPD patients compared to large trial populations: An UNLOCK external validity study Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The impact of comorbidities on mortality in COPD, report from the OLIN COPD study. Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Prevalence of COPD: updated meta-analysis results Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008